Dermorphin

Early human Healing & Recovery 2 sources

Dermorphin is a naturally occurring heptapeptide originally isolated from the skin of South American frogs. It acts as a highly potent and selective mu-opioid receptor agonist, demonstrating profound analgesic (pain-relieving) properties in research models. While it shows significantly greater potency than morphine, its clinical use has been limited by typical opioid-related side effects and regulatory restrictions.

01Dosing reference

Amount

Not applicable for general research (highly restricted controlled substance)

Frequency

N/A

Cycle

N/A

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Mu-Opioid Receptor Binding

Dermorphin binds with exceptionally high affinity and selectivity to mu-opioid receptors (MOR) in the central and peripheral nervous systems.

Inhibition of Nociceptive Signaling

Activation of these receptors inhibits the release of neurotransmitters involved in pain signaling, such as substance P, and hyperpolarizes neurons.

Profound Analgesia

This results in a potent and long-lasting antinociceptive (pain-blocking) effect, significantly stronger than traditional opiates like morphine.

03Human evidence

Profound postoperative pain relief

Early clinical trials in the 1980s demonstrated that intrathecal administration of dermorphin provided profound and long-lasting analgesia in patients with postoperative pain, though accompanied by typical opioid side effects.

Efficacy in severe chronic pain

Some early human studies explored its use for severe intractable pain, noting its high potency but also highlighting risks of respiratory depression and tolerance.

04Preclinical evidence

Potent antinociception in animal models

Studies in rodents showed that dermorphin is 30-40 times more potent than morphine when administered intravenously, and even more potent when given centrally.

Receptor internalization and tolerance

Animal research indicates that dermorphin induces significant mu-opioid receptor internalization, which contributes to its pharmacological profile and the development of tolerance.

05What is known vs. unknown

Reasonably established

Dermorphin is a natural heptapeptide originally found in the skin of the Phyllomedusa sauvagei frog.
It is a highly selective and potent agonist of the mu-opioid receptor (MOR).
Research shows it is significantly more potent than morphine in producing analgesia.
It has been studied for severe pain management, particularly via intrathecal administration.

Unknowns & limits

The long-term safety and addiction potential in humans remain poorly characterized compared to traditional opioids.
Its development as a mainstream therapeutic was largely abandoned due to the narrow therapeutic index and typical opioid side effects like respiratory depression.

06Safety & regulatory context

Regulatory statusDermorphin is a potent opioid agonist and carries significant safety risks, including respiratory depression, sedation, tolerance, and high potential for abuse and dependence. It is not approved by the FDA for human use and is strictly regulated or banned in many jurisdictions, including being banned in horse racing due to its illicit use as a performance-enhancing painkiller. Research use requires strict adherence to controlled substance regulations.

07Compared with Morphine

Dermorphin vs. Morphine

Key difference

Dermorphin is a peptide that is significantly more potent and selective for mu-opioid receptors than the alkaloid morphine, but it shares a similar side effect profile.

When researchers discuss each

Morphine is discussed as the gold standard clinical opioid analgesic, whereas dermorphin is discussed in the context of peptide-based opioid pharmacology and evolutionary biology.

08Glossary

Antinociception

The action or process of blocking the detection of a painful or injurious stimulus by sensory neurons.

Mu-Opioid Receptor (MOR)

A class of receptors in the nervous system that are the primary target for opioid drugs, mediating pain relief, euphoria, and respiratory depression.

Intrathecal

Administration of a substance directly into the spinal canal to reach the cerebrospinal fluid.

09Knowledge check

Q1What is the primary mechanism of action for dermorphin?

Q2Where was dermorphin originally discovered?

Q3Which statement best reflects a documented limitation of dermorphin in the supplied dossier?

Q4When researchers discuss dermorphin in direct comparison with morphine, in which context is dermorphin primarily framed according to the dossier?

Q5Which regulatory or safety statement about dermorphin is supported by the dossier?

10Sources

More in Healing & Recovery

See all

BPC-157

Healing & Recovery

Early human

BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.

250-500 mcg

TB-500 (Thymosin Beta-4)

Healing & Recovery

Early human

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.

2.0 - 2.5 mg per injection

KPV

Healing & Recovery

Early human

KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.

200-500 mcg/day

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.